A phyllodes tumor is a rare breast growth that develops in the connective tissue of the breast, accounting for less than 1 percent of all breast tumors. Unlike the far more common breast cancers that start in the milk ducts or lobules, phyllodes tumors arise from the supportive tissue (called stroma) that surrounds those structures. The name comes from the Greek word “phyllon,” meaning leaf, because under a microscope the tumor forms leaf-like fronds that protrude into fluid-filled spaces.
How Phyllodes Tumors Differ From Fibroadenomas
Phyllodes tumors and fibroadenomas are closely related. Both grow from the same type of connective tissue, and they share enough microscopic features that distinguishing them can be genuinely difficult, even for experienced pathologists. The critical difference is behavior. Fibroadenomas are the most common benign breast lump in women and almost never recur or spread. Phyllodes tumors, on the other hand, can recur after removal, progress to a higher grade over time, and in some cases metastasize to distant organs.
This is why a lump initially thought to be a fibroadenoma sometimes turns out to be a phyllodes tumor once it’s removed and examined more closely. A core needle biopsy can suggest the diagnosis, but the full picture often requires analyzing the entire specimen.
The Three Grades: Benign, Borderline, and Malignant
Phyllodes tumors are classified into three categories based on what the tissue looks like under a microscope. The grading system relies on several features of the connective tissue component: how densely packed the cells are, how quickly they’re dividing, whether the tumor’s edges push smoothly against surrounding tissue or infiltrate into it, and whether the connective tissue is overgrowing the normal glandular elements.
- Benign phyllodes tumors have smooth, well-defined borders that push against surrounding tissue rather than invading it. Cell density is only mildly increased, and dividing cells are rare.
- Borderline tumors show moderate increases in cell density, more frequent cell division, and borders that may start to creep into nearby tissue in some areas.
- Malignant phyllodes tumors have markedly dense cell populations, frequent cell division, and borders that clearly invade surrounding breast tissue.
Most phyllodes tumors fall into the benign category. The distinction matters because grade strongly influences the risk of the tumor coming back or spreading.
Who Gets Them and What They Feel Like
Phyllodes tumors most commonly appear in women between 42 and 45 years old, though they’ve been diagnosed in patients ranging from age 10 to 82. They occur overwhelmingly in women, with cases in men being exceptionally rare.
The typical presentation is a firm, smooth, well-defined lump in the breast. Most are larger than 3 centimeters at the time they’re discovered, and some grow considerably bigger. One of the hallmark features that raises suspicion is speed: a phyllodes tumor can grow noticeably in a matter of weeks. If the tumor gets large enough to stretch the overlying skin, the skin may look shiny or translucent and can become tender.
This rapid growth is often what prompts a visit to a doctor. A lump that was small or unnoticed a few weeks ago suddenly becomes obvious and concerning.
How They’re Diagnosed
On mammography, phyllodes tumors typically appear as well-defined, round or oval masses, making them look similar to fibroadenomas or cysts. Ultrasound provides more detail and can reveal features that raise suspicion, particularly the presence of internal fluid-filled clefts or cystic areas within the mass. These clefts and complex cystic patterns are more common in malignant phyllodes tumors than in benign ones.
Imaging alone can’t reliably distinguish a phyllodes tumor from a large fibroadenoma. A core needle biopsy helps, but the definitive diagnosis usually comes after the entire tumor is surgically removed and examined. Pathologists look at the full specimen to assess cell density, growth patterns, and borders, features that a small biopsy sample can miss or misrepresent.
Surgery Is the Primary Treatment
Surgery is the cornerstone of phyllodes tumor treatment, regardless of grade. The goal is to remove the tumor with a margin of healthy tissue around it to reduce the chance of recurrence. There’s no universal agreement on exactly how wide that margin needs to be. Guidelines from MD Anderson Cancer Center note that no high-level evidence supports a specific margin width, and the decision about re-excision depends on factors like the tumor’s pathologic features, how large the tumor is relative to the breast, and cosmetic outcomes.
For benign phyllodes tumors, if the tumor is fully removed with clear margins, re-excision is not recommended regardless of how narrow the margin is. For borderline and malignant tumors, surgeons generally aim for wider margins when feasible, and mastectomy may be considered for very large tumors or when adequate margins can’t be achieved with breast-conserving surgery.
Radiation therapy is sometimes used after surgery for malignant phyllodes tumors, particularly when margins are close or the tumor is large. Standard chemotherapy and hormonal therapies used for typical breast cancers are generally not effective here, because phyllodes tumors arise from connective tissue rather than glandular cells.
Recurrence and Long-Term Outlook
Phyllodes tumors can come back in the same breast after removal, and the risk increases with grade. A large Dutch population study covering over 900 cases found that the five-year local recurrence rate was about 8.7 percent for borderline tumors and 11.7 percent for malignant ones. Benign phyllodes tumors recur less frequently, though they can, which is why follow-up monitoring matters even with a benign diagnosis.
Distant metastasis, where the tumor spreads to other organs, occurs only with malignant phyllodes tumors. The five-year rate in that same study was 4.7 percent. When spread does occur, the lungs are the most common site. Benign and borderline tumors do not metastasize, though a borderline tumor that recurs can sometimes return at a higher grade.
The overall prognosis for most people with phyllodes tumors is good. The vast majority are benign, and even among malignant cases, the rate of distant spread remains relatively low. Regular follow-up with imaging after surgery helps catch any recurrence early, when it’s most treatable.